Skip to main content
SpringerLink
Log in

Role of Nanobiotechnology in Drug Delivery

  • Protocol
  • First Online:
Drug Delivery Systems

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2059))

Abstract

This chapter is a brief overview of use of nanobiotechnology in drug delivery. Several types of nanoparticles are available. Nanoparticulate formulations of normally used drugs have increased efficacy due to improved absorption and require lower dosage with less side effects than standard formulations. Nanobiotechnology also facilitates targeted drug delivery of anticancer drugs, which is important for the management of cancer. Nanoparticles also facilitate crossing of biological barriers in the human body for drug delivery to targeted organs, for example, crossing the blood–brain barrier to reach the brain. Nanobiotechnology applications in delivery of biological therapies are expanding in areas such as cell and gene therapies, siRNAs, and monoclonal antibodies. Some nanoparticles can carry more than one therapeutic molecule enabling multimodal therapy and combination with physical modalities such as radiotherapy in cancer. Nanorobotics is developing with applications in drug delivery, particularly for cancer. Other anticipated developments in this area include use of nanotechnology for creating intelligent drug release devices.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jain KK (2019) Nanobiotechnology: technologies, markets & companies. Jain PharmaBiotech Publications, Basel

    Google Scholar 

  2. Jain KK (2017) Handbook of nanomedicine, 3rd edn. Springer, New York, NY

    Book  Google Scholar 

  3. Dobrovolskaia MA, Patri AK, Zheng J et al (2009) Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomedicine 5:106–117

    Article  CAS  Google Scholar 

  4. Hoare T, Santamaria J, Goya GF et al (2009) A magnetically triggered composite membrane for on-demand drug delivery. Nano Lett 9:3651–3657

    Article  CAS  Google Scholar 

  5. Patel VR, Agrawal YK (2011) Nanosuspension: an approach to enhance solubility of drugs. J Adv Pharm Technol Res 2:81–87

    Article  CAS  Google Scholar 

  6. Yao L, Zhao X, Li Q et al (2012) In vitro and in vivo evaluation of camptothecin nanosuspension: a novel formulation with high antitumor efficacy and low toxicity. Int J Pharm 423:586–588

    Article  CAS  Google Scholar 

  7. Suri GS, Kaur A, Sen T (2016) A recent trend of drug-nanoparticles in suspension for the application in drug delivery. Nanomedicine (Lond) 11:2861–2876

    CAS  Google Scholar 

  8. Brudno Y, Silva EA, Kearney CJ et al (2014) Refilling drug delivery depots through the blood. Proc Natl Acad Sci U S A 111:12722–12727

    Article  CAS  Google Scholar 

  9. Yamada Y, Harashima H (2014) A method for screening mitochondrial fusogenic envelopes for use in mitochondrial drug delivery. Methods Mol Biol 1141:57–66

    Article  CAS  Google Scholar 

  10. Mishra V, Kesharwani P, Jain NK (2014) siRNA nanotherapeutics: a Trojan horse approach against HIV. Drug Discov Today 19:1913–1920

    Article  CAS  Google Scholar 

  11. Tajmir-Riahi HA, Nafisi S, Sanyakamdhorn S, Agudelo D, Chanphai P (2014) Applications of chitosan nanoparticles in drug delivery. Methods Mol Biol 1141:165–184

    Article  CAS  Google Scholar 

  12. Malhotra M, Tomaro-Duchesneau C, Saha S, Prakash S (2014) Intranasal delivery of chitosan-siRNA nanoparticle formulation to the brain. Methods Mol Biol 1141:233–247

    Article  CAS  Google Scholar 

  13. Torne S, Darandale S, Vavia P et al (2013) Cyclodextrin-based nanosponges: effective nanocarrier for Tamoxifen delivery. Pharm Dev Technol 18:619–625

    Article  CAS  Google Scholar 

  14. Carmona-Moran CA, Zavgorodnya O, Penman AD et al (2016) Development of gellan gum containing formulations for transdermal drug delivery: component evaluation and controlled drug release using temperature responsive nanogels. Int J Pharm 509:465–476

    Article  CAS  Google Scholar 

  15. Stoicea N, Fiorda-Diaz J, Joseph N et al (2017) Advanced analgesic drug delivery and nanobiotechnology. Drugs 77:1069–1076

    Article  CAS  Google Scholar 

  16. Jain KK (2019) An overview of drug delivery systems. In: Jain KK (ed) Drug delivery systems, 3rd edn. Humana Springer, New York, NY

    Google Scholar 

  17. Jain KK (2012) Nanobiotechnology-based strategies for crossing the blood-brain barrier. Nanomedicine (Lond) 7:1225–1233

    Article  CAS  Google Scholar 

  18. Seth A, Oh DB, Lim YT (2015) Nanomaterials for enhanced immunity as an innovative paradigm in nanomedicine. Nanomedicine (Lond) 10:959–975

    Article  CAS  Google Scholar 

  19. Chahal JS, Khan OF, Cooper CL et al (2016) Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose. Proc Natl Acad Sci U S A 113:E4133–E4142

    Article  CAS  Google Scholar 

  20. Nuhn L, Vanparijs N, De Beuckelaer A et al (2016) pH-degradable imidazoquinoline-ligated nanogels for lymph node-focused immune activation. Proc Natl Acad Sci U S A 113:8098–8103

    Article  CAS  Google Scholar 

  21. Kammona O, Bourganis V, Karamanidou T, Kiparissides C (2017) Recent developments in nanocarrier-aided mucosal vaccination. Nanomedicine (Lond) 12:1057–1074

    Article  CAS  Google Scholar 

  22. Jain KK (2019) Cell therapy: technologies, markets & companies. Jain PharmaBiotech Publications, Basel

    Google Scholar 

  23. Jain KK (2019) Gene therapy: technologies, markets and companies. Jain PharmaBiotech Publications, Basel

    Google Scholar 

  24. Kasala D, Yoon AR, Hong J et al (2016) Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy. Nanomedicine (Lond) 11:1689–1713

    Article  CAS  Google Scholar 

  25. Pardi N, Tuyishime S, Muramatsu H et al (2015) Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. J Control Release 217:345–351

    Article  CAS  Google Scholar 

  26. Jain KK (2019) Drug delivery in cancer. Jain PharmaBiotech Publications, Basel

    Google Scholar 

  27. Tonigold M, Mailänder V (2016) Endocytosis and intracellular processing of nanoparticles in dendritic cells: routes to effective immunonanomedicines. Nanomedicine (Lond) 11:2625–2630

    Article  CAS  Google Scholar 

  28. Jonuleit H, Bopp T, Becker C (2016) Treg cells as potential cellular targets for functionalized nanoparticles in cancer therapy. Nanomedicine (Lond) 11:2699–2709

    Article  CAS  Google Scholar 

  29. Tuettenberg A, Steinbrink K, Schuppan D (2016) Myeloid cells as orchestrators of the tumor microenvironment: novel targets for nanoparticular cancer therapy. Nanomedicine (Lond) 11:2735–2751

    Article  CAS  Google Scholar 

  30. Yu G, Zhu B, Shao L et al (2019) Host-guest complexation-mediated codelivery of anticancer drug and photosensitizer for cancer photochemotherapy. Proc Natl Acad Sci U S A 116:6618–6623

    Article  CAS  Google Scholar 

  31. Schuerle S, Soleimany AP, Yeh T et al (2019) Synthetic and living micropropellers for convection-enhanced nanoparticle transport. Sci Adv 5(4):eaav4803

    Article  CAS  Google Scholar 

  32. Douglas SM, Bachelet I, Church GM (2012) A logic-gated nanorobot for targeted transport of molecular payloads. Science 335:831–834

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Jain PharmaBiotech, Basel, Switzerland

    Kewal K. Jain

Authors
  1. Kewal K. Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kewal K. Jain .

Editor information

Editors and Affiliations

  1. Jain PharmaBiotech, Basel, Switzerland

    Kewal K. Jain

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Jain, K.K. (2020). Role of Nanobiotechnology in Drug Delivery. In: Jain, K. (eds) Drug Delivery Systems. Methods in Molecular Biology, vol 2059. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9798-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-9798-5_2

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-4939-9797-8

  • Online ISBN: 978-1-4939-9798-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation